


IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. Email Formats
Pharmaceutical Manufacturing • Aprilia, Latium, Italy • 201-500 Employees
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. Email Formats
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. uses 3 email formats. The most common is {first name}{last name} (e.g., johndoe@ibi-lorenzini.com), used 91.9% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@ibi-lorenzini.com | 91.9% |
{first initial}{last name} | jdoe@ibi-lorenzini.com | 7.1% |
{last name}{first initial} | doej@ibi-lorenzini.com | 1% |
Key Contact at IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.
Company overview
| Headquarters | Via di Fossignano 2, Aprilia, 04011, IT |
| Phone number | +3906921501 |
| Websites | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Retail, Pharmaceutical, Veterinary, RNA, Aseptic Filling, Hospital, Antibiotics, Drug, Vitamin, Proteins, Generics, Peptides, Nanotech, Monoclonal Antibodies, Contract Manufacturing Services, Biological Medicinal Products, Injectable Medicinal Products, Licencing In, Licencing Out, Nanocarriers |
| Founded | 1918 |
| Employees | 201-500 |
| Socials |
About IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.
IBI (Istituto Biochimico Italiano G. Lorenzini Spa) is a leading international biopharmaceutical company that has been operating since 1918. Specializing in aseptic manufacturing of Injectable Medicinal Products, IBI has established direct commercial presence in the UK, Germany, and Italy, while also exporting through alliances to more than 20 countries worldwide, including the US, Australia, and Europe. IBI offers comprehensive CDMO services, including advanced formulation, process development, and GMP manufacturing of sterile finished products. Their expertise extends to developing solutions and freeze-dried powders for both chemical and biotech active ingredients, such as small molecules, monoclonal antibodies, recombinant proteins, oligonucleotides, and nanoparticle technologies. IBI is certified by FDA, AIFA (EU), EDQM, TGA. More information: www.ibi-lorenzini.com Business Development: bd@ibi-lorenzini.com • GMP production for biological medicinal products (active substance from CHO cell culture, peptides, monoclonal antibodies) • GMP production of sterile drug products • GMP production of sterile API and finished products • CDMO and GMP production for orals, topicals, injectables • Aseptic filling of injectable medicinal products • Micro and nanoparticles formulations aimed to delivery of different classes of active molecules • Pharmaceutical development • Analytical validations, stability testing • MA and IMP registration and Batch Release services • Investigational Medicinal Product production
Employees by Management Level
Total employees: 201-500
Seniority
Employees
Employees by Department
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. has 84 employees across 14 departments.
Departments
Number of employees
Funding Data
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. has never raised funding before.
IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a. Tech Stack
Discover the technologies and tools that power IBI - Istituto Biochimico Italiano Giovanni Lorenzini S.p.a.'s digital infrastructure, from frameworks to analytics platforms.
Security
JavaScript libraries
Tag managers
Caching
Reverse proxies
Programming languages
Miscellaneous
Video players
UI frameworks
Analytics
Maps
Miscellaneous
Frequently asked questions
4.8
40,000 users



